Neogen Chemicals Limited (NSE:NEOGEN)
India · Delayed Price · Currency is INR 2,831.00
+60.80 (2.19%)
Nov 12, 2026, 3:29 PM IST
Neogen Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 10,128 | 8,620 | 7,776 | 6,907 | 6,862 | 4,873 | |
Revenue Growth | 26.66% | 10.85% | 12.58% | 0.65% | 40.83% | 44.84% |
Cost of Revenue | 5,604 | 4,765 | 4,289 | 3,876 | 3,940 | 2,750 |
Gross Profit | 4,524 | 3,855 | 3,486 | 3,031 | 2,922 | 2,123 |
Selling, General & Admin | 1,091 | 967 | 684.3 | 659.9 | 499.6 | 334.1 |
Other Operating Expenses | 1,739 | 1,515 | 1,439 | 1,272 | 1,307 | 924.4 |
Operating Expenses | 3,144 | 2,757 | 2,401 | 2,159 | 1,967 | 1,374 |
Operating Income | 1,380 | 1,098 | 1,085 | 871.8 | 954.2 | 749 |
Interest Expense | -774.4 | -609.8 | -378.6 | -377.8 | -237 | -178 |
Interest & Investment Income | 41.2 | 41.2 | 15.7 | 74.1 | 38.3 | 6 |
Earnings From Equity Investments | 3.5 | 2.8 | 2 | 1.8 | 1 | 1.8 |
Currency Exchange Gain (Loss) | 10.6 | 10.6 | 16.8 | - | - | - |
Other Non Operating Income (Expenses) | -93.8 | -141.3 | -105.3 | -42.2 | -46.2 | -12 |
EBT Excluding Unusual Items | 566.7 | 401.2 | 635.9 | 527.7 | 710.3 | 566.8 |
Gain (Loss) on Sale of Investments | 9.6 | 9.6 | 6.5 | - | - | 3.9 |
Other Unusual Items | - | - | -140.8 | - | - | - |
Pretax Income | 576.3 | 410.8 | 501.6 | 527.7 | 710.3 | 570.7 |
Income Tax Expense | 171.9 | 123.3 | 153.3 | 171.2 | 210.6 | 124.4 |
Net Income | 404.4 | 287.5 | 348.3 | 356.5 | 499.7 | 446.3 |
Net Income to Common | 404.4 | 287.5 | 348.3 | 356.5 | 499.7 | 446.3 |
Net Income Growth | 55.12% | -17.46% | -2.30% | -28.66% | 11.96% | 42.45% |
Shares Outstanding (Basic) | 27 | 26 | 26 | 26 | 25 | 25 |
Shares Outstanding (Diluted) | 27 | 26 | 26 | 26 | 25 | 25 |
Shares Change | 2.29% | - | 3.29% | 2.41% | - | 6.88% |
EPS (Basic) | 15.00 | 10.90 | 13.20 | 13.96 | 20.04 | 17.90 |
EPS (Diluted) | 15.00 | 10.90 | 13.20 | 13.96 | 20.03 | 17.90 |
EPS Growth | 51.69% | -17.44% | -5.43% | -30.31% | 11.93% | 33.28% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -9,167 | -7,872 | -1,217 | -3,319 | -1,328 | -1,689 |
Free Cash Flow Per Share | -340.00 | -298.38 | -46.13 | -129.96 | -53.27 | -67.71 |
Dividend Per Share | - | 1.000 | 1.000 | 2.000 | 3.000 | 2.750 |
Dividend Growth | - | 0% | -50.00% | -33.33% | 9.09% | 22.22% |
Gross Margin | 44.67% | 44.72% | 44.84% | 43.88% | 42.58% | 43.57% |
Operating Margin | 13.62% | 12.73% | 13.96% | 12.62% | 13.91% | 15.37% |
Profit Margin | 3.99% | 3.33% | 4.48% | 5.16% | 7.28% | 9.16% |
Free Cash Flow Margin | -90.51% | -91.33% | -15.65% | -48.06% | -19.36% | -34.66% |
EBITDA | 1,587 | 1,266 | 1,293 | 1,054 | 1,094 | 848.6 |
EBITDA Margin | 15.67% | 14.69% | 16.63% | 15.26% | 15.95% | 17.42% |
D&A For EBITDA | 207.3 | 168.3 | 208.1 | 181.9 | 140.1 | 99.6 |
EBIT | 1,380 | 1,098 | 1,085 | 871.8 | 954.2 | 749 |
EBIT Margin | 13.62% | 12.73% | 13.96% | 12.62% | 13.91% | 15.37% |
Effective Tax Rate | 29.83% | 30.01% | 30.56% | 32.44% | 29.65% | 21.80% |
Revenue as Reported | 10,237 | 8,681 | 7,816 | 6,981 | 6,906 | 4,883 |